810156C

18:1-12:0 NBD PE

Avanti Research^™ - A Croda Brand 810156C

• Synonym(e): 1-oleoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphoethanolamine
• Empirische Formel (Hill-System): C₄₁H₇₀N₅O₁₁P
• CAS-Nummer: 321594-90-5
• Molekulargewicht: 840.00
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Assay: >99% (TLC)
• Form: liquid
• Verpackung: pkg of 1 × 1 mL (810156C-1mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 810156C
• Konzentration: 1 mg/mL (810156C-1mg)
• Versandbedingung: dry ice
• Lagertemp.: −20°C

Beschreibung

Allgemeine Beschreibung

N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) phosphoethanolamine (NBD PE) is localized at the membrane interface. Fluorescent NBD label is covalently linked to the headgroup of phosphatidylethanolamine. Phosphoethanolamine is mostly present in brain and is the second most abundant, metabolically related aminophospholipid.

Anwendung

18:1-06:0 NBD PE may be used as a component of liposome in cross-linking experiment and to determine M13 coat protein selectivity toward phospholipids headgroups.

Biochem./physiol. Wirkung

N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) phosphoethanolamine (NBD PE) plays a key role as a fluorescent analog in the studies of organization and dynamics of membranes. NBD PE contributes in monitoring Red edge excitation shift (REES) effects with the unique motional and dielectric properties it possesses.

Verpackung

5 mL Amber Glass Screw Cap Vial (810156C-1mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• P-Sätze: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• Gefahreneinstufungen: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Zielorgane: Central nervous system, Liver,Kidney
• WGK: WGK 3